Ladenburg Thalmann Maintains Buy on Harrow, Raises Price Target to $66

HARROW HEALTH INC +1.79%

HARROW HEALTH INC

HROW

51.10

+1.79%

Ladenburg Thalmann analyst Jeffrey Cohen maintains Harrow (NASDAQ: HROW) with a Buy and raises the price target from $64 to $66.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via